Cochlear Limited (ASX:COH) and this ASX 200 blue chip share could be great options for investors in May. Here’s what you need to know…
The post 2 ASX 200 blue chip shares rated as buys appeared first on The Motley Fool Australia. –
Are you wanting to buy some blue chip ASX 200 shares for your portfolio? If you are, then I would suggest you check out the two listed below.
These quality companies could have the potential to grow at a solid rate over the next decade. As a result of this, they have been tipped as blue chips to buy. Here’s why:
Cochlear Limited (ASX: COH)
The first ASX 200 blue chip share to look at is Cochlear. It is a global leader in the development, manufacture, and distribution of cochlear implantable devices for the hearing impaired.
Among its growing portfolio of world class products you will find the Nucleus Profile Plus Series cochlear implant and the Nucleus Kanso 2 Sound Processor.
While the pandemic had a big impact on the company due to the deferral of elective surgeries, the company has bounced back strongly. For example, in February Cochlear released its half year results and reported an underlying net profit of $125.3 million.
While this was down 4% on the prior corresponding period, it is worth remembering that the prior period was before COVID-19 was a thing. Not only that, it was also a record first half profit.
Looking ahead, the company looks well-placed for growth in the future thanks to the ageing populations tailwind, its strong market position, wide distribution network, and the industry’s high barriers to entry.
Macquarie is a fan of the company. Its analysts currently have an outperform rating and $245.00 price target on Cochlear’s shares.
Woolworths Limited (ASX: WOW)
A second blue chip ASX 200 share that has been rated as a buy is Woolworths. The retail giant has been tipped as a buy due to the favourable outlooks for its key businesses. These include BIG W, BWS, Dan Murphy’s, and the jewel in the crown, Woolworths supermarkets.
In addition to this, the company has just confirmed that it plans to go ahead with its demerger of the Endeavour Drinks business in the very near future. This is expected to strengthen its balance sheet and lead to upwards of $2 billion of capital returns for shareholders.
Macquarie is also a fan of Woolworths. Earlier this week its analysts retained their outperform rating and $44.50 price target on the company’s shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- Top brokers name 3 ASX shares to buy today
- How the Woolworths (ASX:WOW) share price has withstood today’s market selloff
- Woolworths (ASX:WOW) share price higher on PFD acquisition news
- ASX 200 jumps, A2 Milk sinks, Crown rises
- ASX 200 up 1.1%: A2 Milk crashes, Crown-Star $12bn merger, Woolworths update
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of Woolworths Limited. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.